Stigmasterol Ameliorates Pulmonary Hypertension by Suppressing the CCL5/CCR5 Signaling Pathway: Taurocholic Acid as a Downstream Mediator.
BACKGROUND Pulmonary hypertension (PH) is a devastating disease characterized by irreversible pulmonary vascular remodeling (PVR), ultimately culminating in right ventricular failure and death. Although previous studies have demonstrated that stigmasterol (STG) reduces cholesterol levels and prevents cardiovascular dis...